// App-Quantinova.ai

4085 : Comprehensive profiling of biliary tract cancers (BTC) to reveal molecular heterogeneity with implications for matched targeted therapies (MTT).

Researchers

Presenter

  • Tamara Sauri

Principal Investigators

  • Teresa Macarulla

  • Guadalupe Cabrera

  • Helena Verdaguer

  • Fiorella Ruiz

  • Ana Vivancos

  • Jaume Capdevila

  • Elena Elez

  • Maria Alsina

  • Guillem Argiles

  • Cinta Hierro

  • Julieta Grasselli

  • Ignacio Matos

  • Jordi Rodon

  • Paolo Nuciforo

  • Rodrigo Dienstmann

  • Josep Tabernero

Medical Centers

  • Vall d'Hebron University Hospital, Barcelona, Spain

  • Vall d Hebron University Hospital (HUVH) and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Instituto Salvadoreno del Seguro Social, El Salvador, El Salvador

  • Oncology Data Science (OdySsey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Cancer Genomics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain

  • Vall d'Hebron Institute of Oncology, Barcelona, Spain

  • Vall d'Hebron University Hospital, Barcelona, Spain

  • Medical Oncology Department, Breast Cancer Group, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain, Barcelona, Spain

  • Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Locations

  • Spain

  • El Salvador

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved